依达拉奉对无精子症的治疗作用:小鼠睾丸组织的自由基清除和自噬调节。

Q2 Medicine
Mahsa Ghaffari Novin, Mohammadamin Sabbagh Alvani, Mohammadreza Mafi Balani, Abbas Aliaghaei, Azar Afshar, Fakhroddin Aghajanpour, Reza Soltani, Hamid Nazarian, Maryam Salimi, Ahad Hasan Seyed Hasani, Shabnam Abdi, Mohammad-Amin Abdollahifar, Pourya Raee
{"title":"依达拉奉对无精子症的治疗作用:小鼠睾丸组织的自由基清除和自噬调节。","authors":"Mahsa Ghaffari Novin,&nbsp;Mohammadamin Sabbagh Alvani,&nbsp;Mohammadreza Mafi Balani,&nbsp;Abbas Aliaghaei,&nbsp;Azar Afshar,&nbsp;Fakhroddin Aghajanpour,&nbsp;Reza Soltani,&nbsp;Hamid Nazarian,&nbsp;Maryam Salimi,&nbsp;Ahad Hasan Seyed Hasani,&nbsp;Shabnam Abdi,&nbsp;Mohammad-Amin Abdollahifar,&nbsp;Pourya Raee","doi":"10.18502/jri.v23i2.8990","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chemotherapeutic agents such as cyclophosphamide and busulfan have been shown to have a negative impact on the spermatogenesis process. Based on this fact, the objective of this study was to investigate the effects of edaravone on spermatogenesis in busulfan-induced mice.</p><p><strong>Methods: </strong>Forty adult male mice were equally divided into the four groups: 1) control, 2) edaravone, 3) busulfan, and 4) busulfan + edaravone. Then, the sperm parameters, histopathological examinations, and serum levels of testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were also assessed. Caspase-3, Beclin-1, and ATG-7 mRNA levels were also determined using real-time PCR.</p><p><strong>Results: </strong>Our results revealed that treatment of mice with edaravone in busulfan-induced azoospermia significantly improves sperm parameters, including total count, morphology, and viability (p<0.05). Furthermore, edaravone administration led to a significant increase in serum testosterone (p<0.0001) and FSH (p<0.001) levels, as well as testis weight (p<0.05) and volume (p<0.01). Edaravone also prevented a decrease in the number of testicular cells including spermatogonia (p<0.0001), primary spermatocytes (p<0.001), round spermatids (p<0.0001), Sertoli (p<0.01), and Leydig cells (p<0.0001) in busulfan-treated mice. Additionally, in busulfan-induced azoospermia, edaravone significantly reduced the percentage of sperm with immature chromatin (p<0.0001). Following treatment with edaravone, a decrease in reactive oxygen species (ROS) and an increase in glutathione (GSH) production were noted compared to busulfan-treated mice. Furthermore, caspase-3 (p<0.05), Beclin-1, and ATG-7 (p<0.001) genes expression decreased significantly in treatment groups compared to busulfan-induced azoospermia.</p><p><strong>Conclusion: </strong>According to our findings, edaravone can improve spermatogenesis in busulfan-induced azoospermia through free radical scavenging and autophagy modulation in testicular tissue.</p>","PeriodicalId":38826,"journal":{"name":"Journal of Reproduction and Infertility","volume":"23 2","pages":"73-83"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/78/JRI-23-73.PMC9363905.pdf","citationCount":"2","resultStr":"{\"title\":\"Therapeutic Effects of Edaravone on Azoospermia: Free Radical Scavenging and Autophagy Modulation in Testicular Tissue of Mice.\",\"authors\":\"Mahsa Ghaffari Novin,&nbsp;Mohammadamin Sabbagh Alvani,&nbsp;Mohammadreza Mafi Balani,&nbsp;Abbas Aliaghaei,&nbsp;Azar Afshar,&nbsp;Fakhroddin Aghajanpour,&nbsp;Reza Soltani,&nbsp;Hamid Nazarian,&nbsp;Maryam Salimi,&nbsp;Ahad Hasan Seyed Hasani,&nbsp;Shabnam Abdi,&nbsp;Mohammad-Amin Abdollahifar,&nbsp;Pourya Raee\",\"doi\":\"10.18502/jri.v23i2.8990\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Chemotherapeutic agents such as cyclophosphamide and busulfan have been shown to have a negative impact on the spermatogenesis process. Based on this fact, the objective of this study was to investigate the effects of edaravone on spermatogenesis in busulfan-induced mice.</p><p><strong>Methods: </strong>Forty adult male mice were equally divided into the four groups: 1) control, 2) edaravone, 3) busulfan, and 4) busulfan + edaravone. Then, the sperm parameters, histopathological examinations, and serum levels of testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were also assessed. Caspase-3, Beclin-1, and ATG-7 mRNA levels were also determined using real-time PCR.</p><p><strong>Results: </strong>Our results revealed that treatment of mice with edaravone in busulfan-induced azoospermia significantly improves sperm parameters, including total count, morphology, and viability (p<0.05). Furthermore, edaravone administration led to a significant increase in serum testosterone (p<0.0001) and FSH (p<0.001) levels, as well as testis weight (p<0.05) and volume (p<0.01). Edaravone also prevented a decrease in the number of testicular cells including spermatogonia (p<0.0001), primary spermatocytes (p<0.001), round spermatids (p<0.0001), Sertoli (p<0.01), and Leydig cells (p<0.0001) in busulfan-treated mice. Additionally, in busulfan-induced azoospermia, edaravone significantly reduced the percentage of sperm with immature chromatin (p<0.0001). Following treatment with edaravone, a decrease in reactive oxygen species (ROS) and an increase in glutathione (GSH) production were noted compared to busulfan-treated mice. Furthermore, caspase-3 (p<0.05), Beclin-1, and ATG-7 (p<0.001) genes expression decreased significantly in treatment groups compared to busulfan-induced azoospermia.</p><p><strong>Conclusion: </strong>According to our findings, edaravone can improve spermatogenesis in busulfan-induced azoospermia through free radical scavenging and autophagy modulation in testicular tissue.</p>\",\"PeriodicalId\":38826,\"journal\":{\"name\":\"Journal of Reproduction and Infertility\",\"volume\":\"23 2\",\"pages\":\"73-83\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/78/JRI-23-73.PMC9363905.pdf\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Reproduction and Infertility\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18502/jri.v23i2.8990\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Reproduction and Infertility","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/jri.v23i2.8990","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

摘要

背景:化疗药物如环磷酰胺和丁硫凡已被证明对精子发生过程有负面影响。基于这一事实,本研究的目的是探讨依达拉奉对布苏芬诱导小鼠精子发生的影响。方法:将40只成年雄性小鼠随机分为4组:1)对照组,2)依达拉奉组,3)busulfan组,4)busulfan +依达拉奉组。然后,评估精子参数、组织病理学检查以及血清睾酮、促卵泡激素(FSH)和黄体生成素(LH)水平。real-time PCR检测Caspase-3、Beclin-1和ATG-7 mRNA水平。结果:我们的研究结果显示,用依达拉奉治疗布苏芬诱导的无精子症小鼠,可显著改善精子参数,包括总数、形态和活力(p结论:根据我们的研究结果,依达拉奉可以通过清除睾丸组织中的自由基和调节自噬来改善布苏芬诱导的无精子症的精子发生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Therapeutic Effects of Edaravone on Azoospermia: Free Radical Scavenging and Autophagy Modulation in Testicular Tissue of Mice.

Background: Chemotherapeutic agents such as cyclophosphamide and busulfan have been shown to have a negative impact on the spermatogenesis process. Based on this fact, the objective of this study was to investigate the effects of edaravone on spermatogenesis in busulfan-induced mice.

Methods: Forty adult male mice were equally divided into the four groups: 1) control, 2) edaravone, 3) busulfan, and 4) busulfan + edaravone. Then, the sperm parameters, histopathological examinations, and serum levels of testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were also assessed. Caspase-3, Beclin-1, and ATG-7 mRNA levels were also determined using real-time PCR.

Results: Our results revealed that treatment of mice with edaravone in busulfan-induced azoospermia significantly improves sperm parameters, including total count, morphology, and viability (p<0.05). Furthermore, edaravone administration led to a significant increase in serum testosterone (p<0.0001) and FSH (p<0.001) levels, as well as testis weight (p<0.05) and volume (p<0.01). Edaravone also prevented a decrease in the number of testicular cells including spermatogonia (p<0.0001), primary spermatocytes (p<0.001), round spermatids (p<0.0001), Sertoli (p<0.01), and Leydig cells (p<0.0001) in busulfan-treated mice. Additionally, in busulfan-induced azoospermia, edaravone significantly reduced the percentage of sperm with immature chromatin (p<0.0001). Following treatment with edaravone, a decrease in reactive oxygen species (ROS) and an increase in glutathione (GSH) production were noted compared to busulfan-treated mice. Furthermore, caspase-3 (p<0.05), Beclin-1, and ATG-7 (p<0.001) genes expression decreased significantly in treatment groups compared to busulfan-induced azoospermia.

Conclusion: According to our findings, edaravone can improve spermatogenesis in busulfan-induced azoospermia through free radical scavenging and autophagy modulation in testicular tissue.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Reproduction and Infertility
Journal of Reproduction and Infertility Medicine-Reproductive Medicine
CiteScore
2.70
自引率
0.00%
发文量
44
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信